Casana (formerly Heart Health Intelligence), a maker of an in-home cardiac health-monitoring smart toilet seat, secured $14 million in a Series A funding round.
The round was led by General Catalyst and the Outsiders Fund with participation from Bemis Manufacturing Company, a manufacturer of toilet seats, and the lead investor for Casana’s seed funding round.
Including the latest funding round, Casana has raised $16.6 million to date.
Casana says it will use the new financing to commercialize its product – the Heart Seat. The company will also plan to pursue FDA clearance for its product.
The Heart Seat is a cloud-connected, self-contained toilet seat-based cardiovascular monitoring system that measures the vital health parameters for assessing heart health.
The company says that its Heart Seat has already been tested through multiple peer-reviewed research studies. By using the passive and consistent home cardiac monitoring data from the Heart Seat, doctors will better understand chronic conditions and address patients’ needs as they arise, the company said.
“Our goal is to be able to monitor a patient’s health more naturally at home, without interruption of their daily routine,” said Austin McChord, CEO of Casana. “The toilet seat is not a tech gadget. Unlike a wearable device, you cannot take it off, forget to use it, or mess it up. If we do our job right, when patients use our effortless in-home heart monitoring device, we are invisible unless their health status needs attention.”
According to the World Health Organization, heart disease remains the leading cause of death globally for the last 20 years and is now killing more people than ever before.
“As medicine moves out of the doctor’s office and into the home, Casana is employing a cutting-edge, user-friendly in-home heart health monitoring device that allows doctors and patients to monitor their cardiac health status from home on a daily basis. The Heart Seat has the potential to both improve patient outcomes with heart disease prevention and decrease the high costs of heart failure in the US,” said Jeffrey Leiden, Chairman of the Board of Casana.
App-connected medical device makers raised nearly $500 million in 2020. Recently, Cue Health (Cue), the creator of an app-connected health monitoring device system, raised $100 million in Series C financing.
